| ○ |
|
池田 康夫 |
早稲田大学 特命教授 |
| 血液学 |
Ikeda Y, Shimada K, Teramoto T, Uchiyama S, Yamazaki T, Oikawa S, Sugawara M, Ando K, Murata M, Yokoyama K, Ishizuka N.
Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
JAMA. 2014 Dec 17;312(23):2510-20.
|
Yukako Ono, Yuhuan Wang, Hidenori Suzuki, Shinichiro Okamoto, Yasuo Ikeda, Mitsuru Murata, Mortimer Poncz, and Yumiko Matsubara.
Induction of functional platelets from mouse and human fibroblasts by p45NF-E2/Maf
Blood blood-2012-02-413617; published ahead of print July 31, 2012,
doi:10.1182 / blood-2012-02-413617
|
Yumiko Matsubara; Yukako Ono; Hidenori Suzuki; Fumio Arai; Toshio Suda; Mitsuru Murata; Yasuo Ikeda
OP9 Bone Marrow Stroma Cells Differentiate into Megakaryocytes and Platelets?
PLoS ONE.?2013;8(3)
|
|
| |
|
小川 行平 |
旭化成ファーマ（株） 医薬事業推進総部 |
| 生化学、薬理学 |
The laminin B2 chain promoter contains unique repeat sequences and is active in transient transfection.
Ogawa K. et al
J.Biol.Chem. 263:8384-8389, 1988
|
Novel tricyclic compounds and drug compositions containing the same.
Miyoshi S., Ogawa K.
WO Patent 1,997,025,311, 1997
|
A novel TIMP-insensitive type IV collagen-degrading metalloproteinase from murine metastatic sarcoma cells.
Kato Y., Ogawa K. et al
FEBS letters 268:39-42, 1990
|
|
| |
|
北村 惣一郎 |
地方行政法人 堺市立病院機構 理事長
国立循環器病研究センター 名誉総長
|
| 心臓血管外科、胸部外科 |
| Kitamura S. Heart transplantation in Japan: a critical appraisal for the results and future prospects. Gen Thorac Cardiovasc Surg. 2012;60:639-644. |
| Kitamura S. Physiological and metabolic effects of grafts in coronary artery bypass surgery. Circ J. 2011;75(4):766-772. |
| Kitamura S, Yagihara T, Kobayashi J, Nakajima H, Toda K, Fujita T, Ichikawa H, Ogino H, Nakatani T, Taniguchi S. Mid- to Long-term Outcomes of Cardiovascular Tissue Replacements Utilizing Homografts Harvested and Stored at Japanese Institutional Tissue Banks. Surg Today. 2011;41:500-509. |
|
| |
|
勝呂 徹 |
東京医科大学医学総合研究所 客員教授
東邦大学名誉教授
|
| 整形外科、関節外科、人工関節 |
| Miyazaki Y, Nakamura T, Kogame K, Saito M, Yamamoto K, Suguro T: Analysis of the Kinematics of Total Knee Prostheses with a Medial Pivot Design. J Arthroplasty. 26 （7）：1038-1044,2011 |
| 勝呂 徹：人工膝関節置換術（TKA）のすべて−安全・確実な手術のために−（勝呂 徹，井上 一編集）：2-12，メジカルビュー社，東京，2007. |
| 勝呂 徹：人工膝関節再置換術，編集勝呂 徹，メジカルビュー社，2009 |
|
| |
|
中釜 斉 |
独立行政法人国立がん研究センター
理事（兼）研究所長
|
| 分子腫瘍学、翻訳制御機構の異常と消化器発がん、環境発がん、比較ゲノミクス |
| Ohki R, Saito K, Chen Y, Kawase T, Hiraoka N, Saigawa R, Minegishi M, Aita Y, Yanai G, Shimizu H, Yachida S, Sakata N, Doi R, Kosuge T, Shimada K, Tycko B, Tsukada T, Kanai Y, Sumi S, Namiki H, Taya Y, Shibata T, Nakagama H. PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors. Proc Natl Acad Sci U S A., 111(23):E2404-13, 2014 |
| Onuma K, Ochiai M, Orihashi K, Takahashi M, Imai T, Nakagama H, Hippo Y. Genetic reconstitution of tumorigenesis in primary intestinal cells. Proc Natl Acad Sci U S A, 110(27):11127-32, 2013 |
| Tsuchiya N, Izumiya M, Ogata-Kawata H, Okamoto K, Fujiwara Y, Nakai M, Okabe A, Schetter AJ, Bowman ED, Midorikawa Y, Sugiyama Y, Aburatani H, Harris CC, Nakagama H. Tumor Suppressor miR-22 Determines p53-Dependent Cellular Fate through Post-transcriptional Regulation of p21. Cancer Res, 71(13):4628-4639, 2011 |
|
| |
|
仲野 徹 |
大阪大学大学院生命機能研究科 教授 |
| 病理学 |
Nakamura T, Liu YU, Nakashima H, Umehara H, Inoue K, Matoba S, Tachibana M, Ogura A, Shinkai Y, Nakano T.
PGC7 binds histone H3K9me2 to protect against conversion of 5MeC to 5HmC in early embryos
Nature, 486: 415-9, 2012
|
Kuramochi-Miyagawa S, Watanabe T, Gotoh K, Takamatasu K, Chuma S, Kojima-Kita K, Shiromoto Y, Asada N, Toyoda A, Fujiyama A, Totoki Y, Shibata T, Kimura T, Nakatsuji N, Noce T, Sasaki H, Nakano T.
MVH in piRNA processing and gene silencing of retrotransposons
Genes Dev, 24:887-892, 2010
|
Kimura T, Tomooka M, Yamano N, Murayama K, Matoba S, Umehara H, Kanai Y, Nakano T
Akt signaling promotes derivation of embryonic germ cells from primordial germ cells
Development, 135:869-79, 2008
|
|
| |
|
西島 正弘 |
昭和薬科大学 学長 |
| 生化学 |
Molecular machinery for non-vesicular trafficking of ceramide
K. Hanada, K. Kumagai, S. Yasuda, Y. Miura, M. Kawano, M. Fukasawa, and M. Nishijima
Nature (Article), 426, 803-809, 2003
|
A Potent Adjuvant Monophosphoryl Lipid A Triggers Various Immune Response, but Not Secretion of lL-1・ or Activation of Caspase-1
K. Okemoto, K. Kawasaki, K. Hanada, M. Miura, and M. Nishijima
J. Immunol., 176, 1203-1208, 2006
|
Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of ceramide
N. Kudo, K. Kumagai, N. Tomishige, T. Yamaji, S. Wakatsuki, M. Nishijima, K. Hanada, and R. Kato
Proc. Natl. Acad. Sci.USA., 105, 488-493, 2008
|
|
| |
|
開 祐司 |
京都大学再生医科学研究所 教授（副所長） |
| 細胞生物学 |
Synthetic disulfide-bridged cyclic peptides mimic the anti-angiogenic actions of chondromodulin-I.
Miura S, Kondo J, Kawakami T, Shukunami C, Aimoto S, Tanaka H, and Hiraki Y.
Cancer Sci. 103: 1311-1318, 2012
|
Differential actions of VEGF-A isoforms on perichondrial angiogenesis during endochondral bone formation.
Takimoto A, Nishizaki Y, Hiraki Y, and Shukunami C.
Dev. Biol., 322: 196-211, 2009
|
Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis.
Yoshioka M, Yuasa S, Matsumura K, Shiomi T, Shukunami C, Okada Y, Mukai M, Shin H, Yozu R, Sata M, Ogawa S, Hiraki Y, and Fukuda K.
Nature Medicine, 12: 1151-1159, 2006
|
|
| |
|
山中 隆幸 |
東京大学大学院 新領域創成科学研究科 准教授 |
| 知的財産権 |
| Yamanaka T, Kodama T, Doi T. Subcellular localization of HCV core protein regulates its ability for p53 activation and p21 suppression. Biochem Biophys Res Commun. 2002 Jun 14;294(3):528-34. |
| Yamanaka T, Uchida M, Doi T. Innate form of HCV core protein plays an important role in the localization and the function of HCV core protein. Biochem Biophys Res Commun. 2002 Jun 14;294(3):521-7. |
| 山中隆幸, 明細書の記載要件に関する考察−実施可能要件・サポート要件を中心として−, パテント誌, 2008, vol.61, No.7, p.4-15（査読なし） |
|
